Relay Therapeutics, Inc.

RLAY · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$74-$70-$77-$76
Dep. & Amort.$1-$0-$0$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$15$19$0
Change in WC-$3-$2-$15$1
Other Non-Cash$15$3$0$15
Operating Cash Flow-$62-$55-$73-$58
Investing Activities
PP&E Inv.$0-$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$58-$9-$22-$75
Inv. Sales/Matur.$98$84$65$104
Other Inv. Act.$0$0$0$0
Investing Cash Flow$40$75$42$29
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$1
Stock Repurch.$0$1$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$1$0$1
Forex Effect$0$0$0$0
Net Chg. in Cash-$22$21-$31-$28
Supplemental Information
Beg. Cash$114$96$126$152
End Cash$92$116$96$124
Free Cash Flow-$62-$55-$74-$58